The Board of Directors of CURE Pharmaceutical Holding Corp. appointed Jessica Rousset as the company’s Chief Operating Officer, effective January 22, 2018, to fill the vacancy resulting from Wayne Nasby’s separation from the Company. Jessica Rousset has been with the Company since March 15, 2017 as the Company’s Chief Business Officer where Mrs. Rousset oversees operations and drives corporate strategy and growth. She is a seasoned business development and commercialization leader, expert in bridging corporate, academic and governmental interests toward the common goal of improving patient’s lives. She brings more than fifteen years of experience fostering innovation in large organizations and advising start-ups to bring novel healthcare solutions to market and into clinical use.